期刊文献+

血清N末端B型钠尿肽原在慢性心力衰竭诊断中的应用浅析 被引量:6

下载PDF
导出
摘要 目的探讨血清N末端B型钠尿肽原诊断慢性心力衰竭的临床应用效果。方法将我院收治的76例就诊疑是慢性心力衰竭患者,作为观察组,选择同期入院健康体检者54名作为对照组。测定两组血浆B型钠尿肽原含量,并进行比较分析。结果本组76例患者与临床诊断符合率为98.7%。敏感性为93.5%,特异性为91.4%。对照组54例,BNP浓度为(41±37)ng/L,观察BNP浓度为(650±440)ng/L。两组BNP浓度经统计学分析,差异有统计学意义(P<0.05)。心功能Ⅳ级BNP浓度显著高于其他心功能等级BNP浓度,差异有统计学意义(P<0.05)。结论 BNP检测在早期诊断及指导治疗、评估预后具有独特优势,值得临床推广应用。
出处 《中国实用医药》 2012年第14期125-126,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献20

  • 1高晶,季称心,边树怀.脑钠素在心血管疾病中的研究进展[J].心血管病学进展,2004,25(6):426-428. 被引量:6
  • 2黄若文,吕卓人,朱长顿.脑钠肽前体评定老年心衰患者心功能的临床意义[J].西安交通大学学报(医学版),2005,26(2):155-157. 被引量:14
  • 3潘柏申,蔡乃绳,李清,范维琥,李勇,郭玮,周琰,陶青.表面健康人群氨基末端B型利钠肽参考范围调查[J].中华检验医学杂志,2006,29(1):23-26. 被引量:66
  • 4张明,于乐.B型钠尿肽在心力衰竭诊断治疗中的应用[J].中国实用内科杂志,2007,27(9):708-710. 被引量:11
  • 5Maisel AS,Koon J,Krishnaswamy P,et al.Utility of B-natriuretic peptide as a rapid point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J].Am Heart J,2001,141(3):367.
  • 6Koglin J,Pehlivanli S,Schwaiblmair M,et al.Role of brain natr:uretic peptide in risk stratification of patients with congestive heart failure[J].JACC,2001,38(7):1934.
  • 7Maisel A.B-type natriuretic peptide levels:diagnostic and prognostic in congestive heart failure:what is next?[J].Circulation,2002,105(20):2328-2331.
  • 8Kawai K,Hata K,Takaoka H,et al.Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy:A potential of hormone-guided treatment[J].Am Heart J,2001,141(6):925-932.
  • 9Williams SG,Ng LL,Obrien RJ,et al.Complementary roles of simple variable,NYHA and N-BNP,in indicating aerobic capacity and severity of heart failure[J].Int J Cardiol,2005,102(2):279-286.
  • 10Lloyd-Jones DM,Larson MG,Leip EP,et al.Lifetime risk for developing congestive heart failure:The Framingham Heart Study[J].Circulation,2002,106:3068-3072.

共引文献48

同被引文献87

  • 1高东奔,邵超华,梁淑兰,裴华,谭艳芬.NT-proBNP对陈旧性心肌梗死患者心力衰竭的诊断价值[J].安徽医学,2013,34(10):1459-1461. 被引量:2
  • 2中华医学会心血管分会.中华心血管杂志编辑委员会,慢性心力衰竭诊断治疗指南.中华心血管杂志,2007,35(12):7-23.
  • 3Lok BY, Dev M, Peter M, et al. Natriuretic peptides, respiratory disease, and the right heart. CHEST,2004,126 (4) : 1330-1336.
  • 4胡安义,梅尚文.心率震荡与慢性心力衰竭患者心功能N末端脑纳肽前体的关系.中华临床医学杂志(电子版),2011,5(7):2062-2065.
  • 5Groenning BA, Nilsson JC, Sondergaard L, et al. Evaluation of im- paired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrational. EJHF,2001,3 (6) :699.
  • 6Dourado VZ,Tanni SE, Vale SA, et al. Systemic manifestations in chronic obstructive pulmonary disease. J Bras Pneumol, 2006,32 (2) :161-171.
  • 7Hynninen KM, Breitve MH,Wiborg AB,et al. Psychological Char- acteristics of patients with chronic obstructive pulmonary disease. J Psychosom Res ,2005,9(9 ) :429-443.
  • 8Davenport C, et 81. Assessing the diagnostic test accuracy of nalriuretie peptides and ECG in the diagnosis of left ventricular systolic dys- function : a systematic review and meta - analysis [ J ]. The British Journal of General Practice, 2006, 56(522) : 48.
  • 9Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1.0 [ updated March 2011 ]. The Coehrane Collaboration, 2011. Available from www. cochrane - handbook, org.
  • 10Devereanx PJ, Yang H, Yusut S, et M. Effects of extended -re- lease metoprolol succinate in patients undergoing non - cardiac surgery (POISE triM) : a randomized controlled triM[ J]. Lancet, 2008, 371(9627) : 1839.

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部